# Safety and Efficacy of Aflibercept in Proliferative Diabetic Retinopathy.

> **NCT02151695** · PHASE2 · COMPLETED · sponsor: **Poitiers University Hospital** · enrollment: 41 (actual)

## Conditions studied

- Naive Patients With Uncomplicated Proliferative Diabetic Retinopathy

## Interventions

- **PROCEDURE:** panretinal photocoagulation
- **DRUG:** Aflibercept intravitreal injections

## Key facts

- **NCT ID:** NCT02151695
- **Lead sponsor:** Poitiers University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05
- **Primary completion:** 2018-10-31
- **Final completion:** 2020-03-06
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2020-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02151695

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02151695, "Safety and Efficacy of Aflibercept in Proliferative Diabetic Retinopathy.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02151695. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*